SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
March 26, 2009	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001047469-09-003196.pdf 0001047469-09-003196.rtf 0001047469-09-003196.xls
March 26, 2009	8-K	Report of unscheduled material events or corporate event	0001104659-09-020163.pdf 0001104659-09-020163.rtf 0001104659-09-020163.xls
March 19, 2009	8-K	Report of unscheduled material events or corporate event	0001104659-09-018805.pdf 0001104659-09-018805.rtf 0001104659-09-018805.xls
March 18, 2009	8-K	Report of unscheduled material events or corporate event	0001104659-09-018594.pdf 0001104659-09-018594.rtf 0001104659-09-018594.xls
March 17, 2009	NT 10-K	Notification that form 10-K will be submitted late	0001104659-09-018029.pdf 0001104659-09-018029.rtf 0001104659-09-018029.xls
February 27, 2009	8-K	Report of unscheduled material events or corporate event	0001104659-09-012778.pdf 0001104659-09-012778.rtf 0001104659-09-012778.xls
February 13, 2009	5	Annual filing director officer or owner of more than ten percent.	0001179110-09-002655.pdf 0001179110-09-002655.rtf
February 13, 2009	5	Annual filing director officer or owner of more than ten percent.	0001179110-09-002657.pdf 0001179110-09-002657.rtf
February 13, 2009	SC 13G/A	An amendment to the SC 13G filing	0001104659-09-009513.pdf 0001104659-09-009513.rtf 0001104659-09-009513.xls
February 13, 2009	SC 13G/A	An amendment to the SC 13G filing	0001104659-09-009514.pdf 0001104659-09-009514.rtf 0001104659-09-009514.xls

Data provided by Kaleidoscope.